BIOTEXNOLOGIYA VA FARMATSIYA INTEGRATSIYASINING ZAMONAVIY MUAMMOLARI VA ISTIQBOLLARI
PDF

Keywords

biotexnologiya, farmatsiya, integratsiya, biologik preparatlar, farmakogenomika, innovatsion texnologiyalar, individualizatsiyalangan terapiya, bioetika, dori vositalarining samaradorligi, gen terapiya.

Abstract

So‘nggi yillarda biotexnologiya va farmatsiya sohalarining integratsiyasi ilmiy-tadqiqot va amaliy tibbiyotda yangi istiqbollarni ochib bermoqda. Ushbu integratsiya biologik mahsulotlarni yaratish, farmakokinetik va farmakodinamik jarayonlarni optimallashtirish, shuningdek, individualizatsiyalangan terapiya strategiyalarini rivojlantirish imkonini beradi. Shu bilan birga, integratsiya jarayonida texnologik, iqtisodiy va normativ-huquqiy muammolar ham yuzaga kelmoqda. Masalan, biotexnologik mahsulotlarning klinik sinovlari va sertifikatlash jarayonlarining murakkabligi, intellektual mulk va bioetik masalalarning tartibga solinmaganligi, shuningdek, ishlab chiqarish samaradorligi va xavfsizlikni ta’minlashdagi qiyinchiliklar asosiy dolzarb muammolar sifatida namoyon bo‘ladi. Shu nuqtai nazardan, farmatsiya va biotexnologiya sohalarining samarali integratsiyasini ta’minlash uchun multidisipliner yondashuv, innovatsion texnologiyalarni joriy etish, xalqaro standartlar va bioetik normalarga rioya qilish zarurati mavjud. Kelajakda biotexnologiya va farmatsiya sohalarining uyg‘un rivojlanishi dori vositalarining sifatini oshirish, terapevtik samaradorlikni kuchaytirish, shuningdek, yangi biologik preparatlar va gen terapiya mahsulotlarini yaratish imkoniyatlarini kengaytiradi. Shu bilan birga, ilmiy-tadqiqot ishlarida sun’iy intellekt va kompyuter modellashuvi kabi zamonaviy vositalarni qo‘llash, farmakogenomika va molekulyar biologiya yondashuvlarini integratsiyalashgan holda tatbiq etish istiqbolli yo‘nalishlardan hisoblanadi

PDF

References

1. Bubela, T., et al. The Ethics and Regulation of Biotechnology. Nature Biotechnology, 30(4), 321–328, 2012.

2. Walsh, G. Biopharmaceuticals: Biochemistry and Biotechnology. 3rd Edition, Wiley, 478 p., 2018.

3. Leader, B., Baca, Q., & Golan, D. Protein therapeutics: a summary and pharmacological classification. Nature Reviews Drug Discovery, 7, 21–39, 2008.

4. Ekins, S. Pharmaceutical Innovation and Biotechnology Integration. Frontiers in Pharmacology, 11, 1234, 2020.

5. Pisano, G. P. Science Business: The Promise, the Reality, and the Future of Biotech. Harvard Business Press, 320 p., 2006.

6. Riedel, T., et al. Biotechnology in personalized medicine: advances and challenges. Drug Discovery Today, 26(5), 1103–1114, 2021.

7. Karimov, A., & Tojiboev, M. Biotexnologiya va tibbiyot: zamonaviy yondashuvlar. Toshkent, O‘zbekiston Respublikasi Tibbiyot nashriyoti, 2020, 256 p.

8. Nazarov, B. Farmatsevtika va biotexnologiya integratsiyasi. Toshkent, Fan va Texnologiya nashriyoti, 2019, 312 p.

9. Singh, R., et al. Emerging trends in biopharmaceutical innovation. Journal of Biotechnology, 248, 12–25, 2017.

10. Kim, J., & Park, H. Monoclonal antibodies and recombinant proteins in therapeutics. Biotech Advances, 35(6), 753–762, 2017.

11. Qodirov, S. Farmakogenomika va individualizatsiyalangan terapiya. Samarqand, Samarqand Davlat Universiteti nashriyoti, 2021, 198 p.

12. Alimov, N. Zamonaviy biotexnologiya va farmatsevtika: klinik va ilmiy aspektlar. Toshkent, Tibbiyot nashriyoti, 2022, 224 p.

13. Ekins, S., & Williams, A. Computational methods in pharmaceutical research. Drug Discovery Today, 25(2), 345–356, 2020.

14. Johnson, M., et al. Regulatory challenges in biopharmaceutical development. Pharmaceutical Regulatory Affairs, 9(3), 112–124, 2018.

15. Abdullayev, D. Biotexnologik preparatlar va ularning xavfsizligi. Toshkent, O‘zbekiston Fanlar Akademiyasi nashriyoti, 2018, 145 p.

16. Lee, K., et al. Integration of biotechnology in personalized medicine. Molecular Therapy, 28(1), 10–22, 2020.